Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] NLMUID: 100883818"" wg kryterium: JN


Tytuł :
Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group.
Autorzy :
Leahy J; National Centre for Pharmacoeconomics, St James's Hospital, Dublin, Ireland. Electronic address: .
Hickey C; National Centre for Pharmacoeconomics, St James's Hospital, Dublin, Ireland.
McConnell D; National Centre for Pharmacoeconomics, St James's Hospital, Dublin, Ireland.
Cassidy O; National Centre for Pharmacoeconomics, St James's Hospital, Dublin, Ireland.
Trela-Larsen L; National Centre for Pharmacoeconomics, St James's Hospital, Dublin, Ireland.
Barry M; National Centre for Pharmacoeconomics, St James's Hospital, Dublin, Ireland.
Tilson L; National Centre for Pharmacoeconomics, St James's Hospital, Dublin, Ireland.
McCullagh L; National Centre for Pharmacoeconomics, St James's Hospital, Dublin, Ireland.
Pokaż więcej
Corporate Authors :
NCPE Review Group; National Centre for Pharmacoeconomics, St James's Hospital, Dublin, Ireland.
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Nov; Vol. 23 (11), pp. 1423-1426. Date of Electronic Publication: 2020 Oct 05.
Typ publikacji :
Editorial
MeSH Terms :
Advisory Committees*
Coronavirus Infections*/drug therapy
Pandemics*
Pneumonia, Viral*/drug therapy
Technology Assessment, Biomedical*
Betacoronavirus ; Budgets ; COVID-19 ; Economics, Pharmaceutical ; Humans ; Quality of Life ; SARS-CoV-2 ; Treatment Outcome ; Withholding Treatment
Opinia redakcyjna
Tytuł :
Is Multicriteria Decision Analysis a Resource Allocation Framework?
Autorzy :
Dionne F; Centre for Clinical Epidemiology and Evaluation, The University of British Columbia, Vancouver, British Columbia. Electronic address: .
Mitton C; Centre for Clinical Epidemiology and Evaluation, The University of British Columbia, Vancouver, British Columbia.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Oct; Vol. 23 (10), pp. 1400-1401. Date of Electronic Publication: 2020 Aug 26.
Typ publikacji :
Letter; Comment
MeSH Terms :
Resource Allocation*
Technology Assessment, Biomedical*
Decision Support Techniques ; Humans
Opinia redakcyjna
Tytuł :
Evaluation of the National Institute for Health and Care Excellence Diagnostics Assessment Program Decisions: Incremental Cost-Effectiveness Ratio Thresholds and Decision-Modifying Factors.
Autorzy :
Chen G; Costello Medical, Cambridge, England, UK.
Peirce V; Costello Medical, Cambridge, England, UK.
Marsh W; Costello Medical, Cambridge, England, UK. Electronic address: .
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Oct; Vol. 23 (10), pp. 1300-1306. Date of Electronic Publication: 2020 Aug 18.
Typ publikacji :
Journal Article
MeSH Terms :
Cost-Benefit Analysis/*methods
Diagnostic Techniques and Procedures/*economics
Technology Assessment, Biomedical/*methods
Decision Making, Organizational ; Diagnostic Techniques and Procedures/standards ; Humans ; Quality-Adjusted Life Years ; State Medicine/organization & administration ; State Medicine/standards ; Technology Assessment, Biomedical/standards ; United Kingdom
Czasopismo naukowe
Tytuł :
Inclusion of Carer Health-Related Quality of Life in National Institute for Health and Care Excellence Appraisals.
Autorzy :
Pennington BM; School of Health and Related Research, University of Sheffield, Sheffield, UK. Electronic address: .
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Oct; Vol. 23 (10), pp. 1349-1357. Date of Electronic Publication: 2020 Aug 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Caregivers*/psychology
Caregivers*/statistics & numerical data
Quality of Life*
Cost-Benefit Analysis/*methods
Technology Assessment, Biomedical/*methods
Humans ; State Medicine ; Technology Assessment, Biomedical/standards ; United Kingdom
Czasopismo naukowe
Tytuł :
Are We Making a Difference? A Qualitative Study of Patient Engagement at the pan-Canadian Oncology Drug Review: Perspectives of Patient Groups.
Autorzy :
Mercer RE; Canadian Centre for Applied Research in Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada.
Chambers A; pan-Canadian Oncology Drug Review, Canadian Agency for Drugs and Technologies in Health, Toronto, Ontario, Canada.
Mai H; pan-Canadian Oncology Drug Review, Canadian Agency for Drugs and Technologies in Health, Toronto, Ontario, Canada.
McDonald V; pan-Canadian Oncology Drug Review, Canadian Agency for Drugs and Technologies in Health, Toronto, Ontario, Canada.
McMahon C; pan-Canadian Oncology Drug Review, Canadian Agency for Drugs and Technologies in Health, Toronto, Ontario, Canada.
Chan KKW; Canadian Centre for Applied Research in Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. Electronic address: .
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Sep; Vol. 23 (9), pp. 1157-1162. Date of Electronic Publication: 2020 Aug 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Patient Participation*
Antineoplastic Agents/*economics
Medical Oncology/*economics
Technology Assessment, Biomedical/*organization & administration
Canada ; Cost-Benefit Analysis ; Decision Making ; Humans ; Qualitative Research
Czasopismo naukowe
Tytuł :
ICER Value Framework 2020 Update: Recommendations on the Aggregation of Benefits and Contextual Considerations.
Autorzy :
Angelis A; Department of Health Policy, London School of Economics, London, England, UK. Electronic address: .
Kanavos P; Department of Health Policy, London School of Economics, London, England, UK.
Phillips LD; Department of Management, London School of Economics, London, England, UK.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Aug; Vol. 23 (8), pp. 1040-1048. Date of Electronic Publication: 2020 Aug 11.
Typ publikacji :
Journal Article
MeSH Terms :
Decision Making*
Technology Assessment, Biomedical/*organization & administration
Algorithms ; Cost-Benefit Analysis ; Decision Support Techniques ; Humans ; Research Design ; United States
Czasopismo naukowe
Tytuł :
Leveraging DICE (Discretely-Integrated Condition Event) Simulation to Simplify the Design and Implementation of Hybrid Models.
Autorzy :
Caro JJ; London School of Economics, London, England, UK; Evidera, Boston, MA, USA. Electronic address: .
Maconachie R; National Institute for Health and Care Excellence (NICE), London, England, UK.
Woods M; London School of Economics, London, England, UK.
Naidoo B; National Institute for Health and Care Excellence (NICE), London, England, UK.
McGuire A; London School of Economics, London, England, UK.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Aug; Vol. 23 (8), pp. 1049-1055. Date of Electronic Publication: 2020 Jun 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Computer Simulation*
Markov Chains*
Models, Statistical*
Technology Assessment, Biomedical/*organization & administration
Decision Support Techniques ; Humans ; Probability
Czasopismo naukowe
Tytuł :
Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions-Report of the ISPOR Stated Preference Research Special Interest Group.
Autorzy :
Marsh K; Evidera, London, England, UK. Electronic address: .
van Til JA; Health Technology and Services Research, University of Twente, Enschede, The Netherlands.
Molsen-David E; Scientific and Health Policy Initiatives, ISPOR, Lawrenceville, NJ, USA.
Juhnke C; Hochschule Neubrandenburg, Neubrandenburg, Germany.
Hawken N; Modus Outcomes, Amsterdam, The Netherlands.
Oehrlein EM; National Health Council, Washington, DC, USA.
Choi YC; University of Minnesota College of Pharmacy, Minneapolis, Minnesota.
Duenas A; ICN Business School, Nancy, France.
Greiner W; Department of Health Economics, Bielefeld University, Bielefeld, Germany.
Haas K; Cerenovus, New Brunswick, NJ, USA.
Hiligsmann M; Department of Health Services Research, Maastricht University, Maastricht, The Netherlands.
Hockley KS; Imperial Clinical Trials Unit, Imperial College London, London, England, UK.
Ivlev I; Center for Health Research, Kaiser Permanente, Portland, OR, USA.
Liu F; Merck & Co, Kenilworth, NJ, USA.
Ostermann J; Department of Health Services Policy and Management, University of South Carolina, Columbia, SC, USA.
Poder T; CIUSSS de l'Estrie-CHUS, Sherbrooke, QC, Canada.
Poon JL; Eli Lilly and Company, Indianapolis, IN, USA.
Muehlbacher A; Hochschule Neubrandenburg, Neubrandenburg, Germany; Department of Population Health Sciences, Duke University, Durham, NC, USA.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Jul; Vol. 23 (7), pp. 831-841. Date of Electronic Publication: 2020 Jul 05.
Typ publikacji :
Journal Article
MeSH Terms :
Patient Preference*
Reimbursement Mechanisms*
Research Design*
Health Services Research/*organization & administration
Technology Assessment, Biomedical/*methods
Biomedical Technology/economics ; Choice Behavior ; Costs and Cost Analysis ; Decision Making ; Decision Support Techniques ; Europe ; Humans ; Pilot Projects ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
A Review of the Methods Used to Generate Utility Values in NICE Technology Assessments for Children and Adolescents.
Autorzy :
Hill H; Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, England, UK. Electronic address: .
Rowen D; Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, England, UK.
Pennington B; Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, England, UK.
Wong R; Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, England, UK.
Wailoo A; Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, England, UK.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Jul; Vol. 23 (7), pp. 907-917. Date of Electronic Publication: 2020 May 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Health Status*
Quality of Life*
Technology Assessment, Biomedical/*methods
Adolescent ; Child ; Cost-Benefit Analysis ; Humans ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Peer Review and Transparency in Evidence-Source Selection in Value and Health Technology Assessment.
Autorzy :
Desai B; University of Maryland, School of Pharmacy, Baltimore, MD, USA. Electronic address: .
Mattingly TJ 2nd; University of Maryland, School of Pharmacy, Baltimore, MD, USA.
van den Broek RWM; Excerpta Medica, Amsterdam, The Netherlands.
Pham N; University of Maryland, School of Pharmacy, Baltimore, MD, USA.
Frailer M; University of Maryland, School of Pharmacy, Baltimore, MD, USA.
Yang J; University of Maryland, School of Pharmacy, Baltimore, MD, USA.
Perfetto EM; University of Maryland, School of Pharmacy, Baltimore, MD, USA; National Health Council, Washington, DC, USA.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Jun; Vol. 23 (6), pp. 689-696. Date of Electronic Publication: 2020 Apr 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Peer Review*
Documentation/*standards
Technology Assessment, Biomedical/*methods
Europe ; Humans ; North America
Czasopismo naukowe
Tytuł :
Research and Policy Impact of Trials Published by the UK National Institute of Health Research (2006-2015).
Autorzy :
Carroll C; School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, England, UK. Electronic address: .
Tattersall A; School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, England, UK.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Jun; Vol. 23 (6), pp. 727-733. Date of Electronic Publication: 2020 Mar 18.
Typ publikacji :
Journal Article
MeSH Terms :
Health Policy*
Technology Assessment, Biomedical*
Periodicals as Topic/*statistics & numerical data
Randomized Controlled Trials as Topic/*statistics & numerical data
Decision Making ; Humans ; Publications/statistics & numerical data ; Publishing/statistics & numerical data ; United Kingdom
Czasopismo naukowe
Tytuł :
Application of Discrete-Event Simulation in Health Technology Assessment: A Cost-Effectiveness Analysis of Alzheimer's Disease Treatment Using Real-World Evidence in Thailand.
Autorzy :
Kongpakwattana K; School of Pharmacy, Monash University Malaysia, Selangor, Malaysia; Global Public Health, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Selangor, Malaysia.
Chaiyakunapruk N; School of Pharmacy, Monash University Malaysia, Selangor, Malaysia; College of Pharmacy, University of Utah, Salt Lake City, UT, USA. Electronic address: .
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Jun; Vol. 23 (6), pp. 710-718. Date of Electronic Publication: 2020 Mar 11.
Typ publikacji :
Journal Article
MeSH Terms :
Quality-Adjusted Life Years*
Technology Assessment, Biomedical*
Alzheimer Disease/*drug therapy
Nootropic Agents/*therapeutic use
Aged ; Aged, 80 and over ; Alzheimer Disease/economics ; Cohort Studies ; Computer Simulation ; Cost-Benefit Analysis ; Decision Support Techniques ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Nootropic Agents/economics ; Retrospective Studies ; Thailand ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Announcing the New Definition of Health Technology Assessment.
Autorzy :
O'Rourke B; Canadian Agency for Drugs and Technologies in Health, Ottawa, ON, Canada.
Oortwijn W; Radboud University Medical Centre, Nijmegen, The Netherlands.
Schuller T; INAHTA Secretariat, Edmonton, AB, Canada.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Jun; Vol. 23 (6), pp. 824-825.
Typ publikacji :
Letter
MeSH Terms :
Terminology as Topic*
Technology Assessment, Biomedical/*methods
Humans ; Internationality
Opinia redakcyjna
Tytuł :
Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group.
Autorzy :
Faulkner E; Evidera, Bethesda, MD, USA; University of North Carolina at Chapel Hill, Chapel Hill, NC; National Association of Managed Care Physicians, Glen Allen, VA, USA. Electronic address: .
Holtorf AP; Health Outcomes Strategies, Basel, Switzerland.
Walton S; University of Illinois at Chicago, Chicago, IL, USA; Second City Outcomes Research, LLC, Chicago, IL, USA.
Liu CY; Methodist Health System, Richardson, TX, USA.
Lin H; National University of Singapore, Singapore.
Biltaj E; University of Utah, Salt Lake City, UT, USA.
Brixner D; University of Utah, Salt Lake City, UT, USA.
Barr C; Strategic Consulting, San Francisco, CA, USA.
Oberg J; Columbia University, New York, NY, USA.
Shandhu G; Gurmit Shandhu Consulting GMBH, Basel, Switzerland.
Siebert U; University for Health Sciences, Medical Informatics, and Technology, Hall in Tirol, Austria; Harvard School of Public Health and Harvard Medical School, Boston, MA, USA; ONCOTYROL Center for Personalized Cancer Medicine, Innsbruck, Austria.
Snyder SR; Georgia State University, Atlanta, GA, USA.
Tiwana S; Amgen, Thousand Oaks, CA, USA.
Watkins J; Premera Blue Cross, Mountlake Terrace, WA, USA.
IJzerman MJ; University of Melbourne Centre for Cancer Research, Parkville, Australia.
Payne K; The University of Manchester, Manchester, England, UK.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 May; Vol. 23 (5), pp. 529-539. Date of Electronic Publication: 2020 Apr 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Economics, Pharmaceutical*
Technology Assessment, Biomedical*
Precision Medicine/*trends
Humans
Czasopismo naukowe
Tytuł :
How Are Incremental Cost-Effectiveness, Contextual Considerations, and Other Benefits Viewed in Health Technology Assessment Recommendations in the United States?
Autorzy :
Trenaman L; Division of Health Policy and Management, Department of Public Sciences, University of California, Davis, Davis, CA, USA; Center for Healthcare Policy and Research, University of California, Davis, Davis, CA, USA. Electronic address: .
Pearson SD; Institute for Clinical and Economic Review, Boston, MA, USA.
Hoch JS; Division of Health Policy and Management, Department of Public Sciences, University of California, Davis, Davis, CA, USA; Center for Healthcare Policy and Research, University of California, Davis, Davis, CA, USA.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 May; Vol. 23 (5), pp. 576-584. Date of Electronic Publication: 2020 Apr 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cost-Benefit Analysis*
Quality-Adjusted Life Years*
Technology Assessment, Biomedical*
Humans ; Quality of Life ; United States
Czasopismo naukowe
Tytuł :
Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing-Based Tests: Challenges, Opportunities, and Potential Solutions.
Autorzy :
Deverka PA; Deverka Consulting, LLC, Apex, NC, USA. Electronic address: .
Douglas MP; Center for Translational and Policy Research on Personalized Medicine, Department of Clinical Pharmacy, University of California at San Francisco, San Francisco, CA, USA.
Phillips KA; Center for Translational and Policy Research on Personalized Medicine, Department of Clinical Pharmacy, University of California at San Francisco, San Francisco, CA, USA; Philip R. Lee Institute for Health Policy, University of California, San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer, University of California at San Francisco, San Francisco, CA, USA.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 May; Vol. 23 (5), pp. 540-550. Date of Electronic Publication: 2020 Mar 26.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Decision Making*
High-Throughput Nucleotide Sequencing*/economics
High-Throughput Nucleotide Sequencing*/trends
Technology Assessment, Biomedical*
Evidence-Based Medicine/*economics
Insurance, Health, Reimbursement/*economics
Economics, Pharmaceutical ; Humans ; Medical Oncology/economics ; Medical Oncology/trends ; Stakeholder Participation ; United States
Czasopismo naukowe
Tytuł :
Shedding Light on Reimbursement Policies of Companion Diagnostics in European Countries.
Autorzy :
Govaerts L; Department of Pharmaceutical and Pharmacological Sciences, Catholic University of Leuven, Leuven, Belgium; Healthcare Management Centre, Vlerick Business School, Ghent, Belgium. Electronic address: .
Simoens S; Department of Pharmaceutical and Pharmacological Sciences, Catholic University of Leuven, Leuven, Belgium.
Van Dyck W; Healthcare Management Centre, Vlerick Business School, Ghent, Belgium.
Huys I; Department of Pharmaceutical and Pharmacological Sciences, Catholic University of Leuven, Leuven, Belgium.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 May; Vol. 23 (5), pp. 606-615. Date of Electronic Publication: 2020 Mar 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Insurance, Health, Reimbursement/*economics
Precision Medicine/*economics
State Medicine/*economics
Technology Assessment, Biomedical/*economics
England ; Europe ; Health Policy ; Humans
Czasopismo naukowe
Tytuł :
Ranking the Criteria Used in the Appraisal of Drugs for Reimbursement: A Stated Preferences Elicitation With Health Technology Assessment Stakeholders Across Jurisdictional Contexts.
Autorzy :
Wranik WD; School of Public Administration, Dalhousie University, Halifax, Canada; College of Economic Analysis, SGH Warsaw School of Economics, Warszawa, Poland; Department of Community Health and Epidemiology, Dalhousie University, Halifax, Canada. Electronic address: .
Jakubczyk M; College of Economic Analysis, SGH Warsaw School of Economics, Warszawa, Poland.
Drachal K; Faculty of Economic Sciences, University of Warsaw, Warszawa, Poland.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Apr; Vol. 23 (4), pp. 471-480. Date of Electronic Publication: 2019 Dec 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Reimbursement Mechanisms*
Antineoplastic Agents/*administration & dosage
Neoplasms/*drug therapy
Technology Assessment, Biomedical/*methods
Antineoplastic Agents/adverse effects ; Antineoplastic Agents/economics ; Choice Behavior ; Humans ; Neoplasms/economics ; Pilot Projects
Czasopismo naukowe
Tytuł :
Association Between the Use of Surrogate Measures in Pivotal Trials and Health Technology Assessment Decisions: A Retrospective Analysis of NICE and CADTH Reviews of Cancer Drugs.
Autorzy :
Pinto A; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
Naci H; Department of Health Policy, London School of Economics and Political Science, London, England, UK. Electronic address: .
Neez E; Department of Health Policy, London School of Economics and Political Science, London, England, UK.
Mossialos E; Department of Health Policy, London School of Economics and Political Science, London, England, UK.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Mar; Vol. 23 (3), pp. 319-327. Date of Electronic Publication: 2020 Jan 13.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Clinical Trials as Topic*
Drug Approval*/economics
Endpoint Determination*
Research Design*
Technology Assessment, Biomedical*/economics
Antineoplastic Agents/*therapeutic use
Neoplasms/*drug therapy
Antineoplastic Agents/adverse effects ; Antineoplastic Agents/economics ; Canada ; Cost-Benefit Analysis ; Decision Support Techniques ; Drug Costs ; Humans ; Models, Economic ; Neoplasms/economics ; Neoplasms/mortality ; Policy Making ; Progression-Free Survival ; Retrospective Studies ; Time Factors ; United Kingdom
Czasopismo naukowe
Tytuł :
Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force.
Autorzy :
Rothery C; Centre for Health Economics, University of York, York, England, UK. Electronic address: .
Strong M; School of Health and Related Research, University of Sheffield, Sheffield, England, UK.
Koffijberg HE; Department of Health Technology & Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands.
Basu A; The Comparative Health Outcomes, Policy, and Economics Institute, School of Pharmacy, University of Washington, Seattle, Washington, DC, USA.
Ghabri S; French National Authority for Health, Paris, France.
Knies S; National Health Care Institute (Zorginstituut Nederland), Diemen, The Netherlands.
Murray JF; Eli Lilly and Company, Indianapolis, IN, USA.
Sanders Schmidler GD; Duke-Margolis Center for Health Policy, Duke Clinical Research Institute and Department of Population Health Sciences, Duke University, Durham, NC, USA.
Steuten L; Office of Health Economics, London, England, UK.
Fenwick E; Pharmerit International, Oxford, England, UK.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Mar; Vol. 23 (3), pp. 277-286.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Decision Support Techniques*
Health Care Costs*/statistics & numerical data
Models, Statistical*
Health Care Rationing/*economics
Health Priorities/*economics
Health Services Needs and Demand/*economics
Needs Assessment/*economics
Technology Assessment, Biomedical/*economics
Consensus ; Cost-Benefit Analysis ; Health Care Rationing/statistics & numerical data ; Health Priorities/statistics & numerical data ; Health Services Needs and Demand/statistics & numerical data ; Humans ; Needs Assessment/statistics & numerical data ; Probability ; Technology Assessment, Biomedical/statistics & numerical data ; Uncertainty
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies